Abstract
Using various monoclonal antibodies to T cell activation molecules it has been shown that purified T cells from patients with active systemic lupus erythematosus overexpress the 4F2, IL-2R (CD25), HLA-DR and T10 antigens. T cells from patients with inactive disease had increased expression of VLA-1 and HLA-DR. Increased T10 expression on T cells from patients with active disease correlated inversely with the production of IL-2, whereas expression of CD25 was slightly increased after 3-day culture with either PHA or anti-CD3. These results provide further evidence of the in vivo activation of T cells in SLE and suggest that such activation comes slowly to a halt upon disease remission.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ADP-ribosyl Cyclase
-
ADP-ribosyl Cyclase 1
-
Adolescent
-
Adult
-
Antibodies, Monoclonal
-
Antigens, CD*
-
Antigens, Differentiation / biosynthesis
-
Antigens, Surface / biosynthesis
-
Biomarkers
-
Cell Division / immunology
-
Female
-
Fluorescent Antibody Technique
-
Fusion Regulatory Protein-1
-
Gene Expression
-
HLA-DR Antigens / biosynthesis
-
Humans
-
Interleukin-2 / biosynthesis*
-
Lupus Erythematosus, Systemic / immunology*
-
Lymphocyte Activation / immunology*
-
Membrane Glycoproteins
-
Middle Aged
-
Receptors, Interleukin-2 / biosynthesis
-
T-Lymphocytes / immunology*
Substances
-
Antibodies, Monoclonal
-
Antigens, CD
-
Antigens, Differentiation
-
Antigens, Surface
-
Biomarkers
-
Fusion Regulatory Protein-1
-
HLA-DR Antigens
-
Interleukin-2
-
Membrane Glycoproteins
-
Receptors, Interleukin-2
-
ADP-ribosyl Cyclase
-
CD38 protein, human
-
ADP-ribosyl Cyclase 1